Revenue (Tables)

9 Months Ended

Sep. 30, 2024

Segment Reporting [Abstract]

Revenue By Product Type

United States revenue by product type is as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
Open ablation	$	30,601	$	25,844	$	90,661	$	77,988
Minimally invasive ablation	11,117		10,893		35,263		31,900
Pain management	16,314		12,591		44,059		36,249
Total ablation	$	58,032	$	49,328	$	169,983	$	146,137
Appendage management	37,420		32,364		111,257		98,647
Total United States	$	95,452	$	81,692	$	281,240	$	244,784

International revenue by product type is as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
Open ablation	$	8,607	$	8,007	$	25,679	$	23,015
Minimally invasive ablation	1,681		1,578		5,559		4,820
Pain management	1,590		547		3,768		1,214
Total ablation	$	11,878	$	10,132	$	35,006	$	29,049
Appendage management	8,580		6,466		24,784		18,869
Total International	$	20,458	$	16,598	$	59,790	$	47,918

Revenue By Geographic Area

Revenue attributed to customer geographic locations is as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
United States	$	95,452	$	81,692	$	281,240	$	244,784
Europe	12,215		9,217		36,193		28,075
Asia Pacific	6,914		6,568		19,916		18,095
Other International	1,329		813		3,681		1,748
Total International	20,458		16,598		59,790		47,918
Total Revenue	$	115,910	$	98,290	$	341,030	$	292,702